These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 20050100

  • 1. Quality of life and efficacy of nebivolol in an open-label study in hypertensive patients. the QoLaN study.
    Hermans MP, De Coster O, Seidel L, Albert A, Van de Borne P.
    Blood Press Suppl; 2009 Oct; 1():5-14. PubMed ID: 20050100
    [Abstract] [Full Text] [Related]

  • 2. Nebivolol in hypertension: a double-blind placebo-controlled multicenter study assessing its antihypertensive efficacy and impact on quality of life.
    Van Bortel LM, Breed JG, Joosten J, Kragten JA, Lustermans FA, Mooij JM.
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):856-62. PubMed ID: 7687708
    [Abstract] [Full Text] [Related]

  • 3. Nationwide efficacy-safety study of nebivolol in mildly hypertensive patients.
    Cleophas TJ, Agrawal R, Lichtenthal A, Mäkel W, Fici F.
    Am J Ther; 2006 Jun; 13(3):192-7. PubMed ID: 16772759
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW.
    Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
    [Abstract] [Full Text] [Related]

  • 5. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
    von Fallois J, Faülhaber HD.
    Fortschr Med Orig; 2000 Jul 27; 118 Suppl 2():77-82. PubMed ID: 15700490
    [Abstract] [Full Text] [Related]

  • 6. Impact of beta-blockers on sleep in patients with mild hypertension: a randomized trial between nebivolol and metoprolol.
    Yilmaz MB, Erdem A, Yalta K, Turgut OO, Yilmaz A, Tandogan I.
    Adv Ther; 2008 Sep 27; 25(9):871-83. PubMed ID: 18758699
    [Abstract] [Full Text] [Related]

  • 7. Comparison of Nebivolol monotherapy versus Nebivolol in combination with other antihypertensive therapies for the treatment of hypertension.
    Papademetriou V.
    Am J Cardiol; 2009 Jan 15; 103(2):273-8. PubMed ID: 19121451
    [Abstract] [Full Text] [Related]

  • 8. [Nebivolol, a beta blocker of the 3rd generation: modern therapy of arterial hypertension. Results of a multicenter observation study].
    von Fallois J, Faulhaber HD.
    Praxis (Bern 1994); 2001 Mar 15; 90(11):435-41. PubMed ID: 11293936
    [Abstract] [Full Text] [Related]

  • 9. Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus.
    Oğuz A, Uzunlulu M, Yorulmaz E, Yalçin Y, Hekim N, Fici F.
    Anadolu Kardiyol Derg; 2007 Dec 15; 7(4):383-7. PubMed ID: 18065333
    [Abstract] [Full Text] [Related]

  • 10. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW.
    Clin Ther; 2009 Mar 15; 31(3):447-62. PubMed ID: 19393838
    [Abstract] [Full Text] [Related]

  • 11. EVOLVE (nebivolol evaluation for efficacy and safety in the treatment of hypertension) postmarketing surveillance study.
    Faruqui AA.
    J Indian Med Assoc; 2007 May 15; 105(5):272, 274, 276-7. PubMed ID: 17915798
    [Abstract] [Full Text] [Related]

  • 12. Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment?
    Schellenberg R, Lichtenthal A, Wöhling H, Graf C, Brixius K.
    Headache; 2008 Jan 15; 48(1):118-25. PubMed ID: 18184294
    [Abstract] [Full Text] [Related]

  • 13. The influence of CYP2D6 phenotype on the clinical response of nebivolol in patients with essential hypertension.
    Lefebvre J, Poirier L, Poirier P, Turgeon J, Lacourciere Y.
    Br J Clin Pharmacol; 2007 May 15; 63(5):575-82. PubMed ID: 17094780
    [Abstract] [Full Text] [Related]

  • 14. Nebivolol: in the treatment of hypertension in the US.
    Baldwin CM, Keam SJ.
    Am J Cardiovasc Drugs; 2009 May 15; 9(4):253-60. PubMed ID: 19655820
    [Abstract] [Full Text] [Related]

  • 15. Differential effects of nebivolol and atenolol on transmitral diastolic filling parameters in patients with essential hypertension.
    Tuncer M, Guntekin U, Gunes Y, Gumrukcuoglu HA, Eryonucu B.
    Adv Ther; 2008 Jun 15; 25(6):619-26. PubMed ID: 18563311
    [Abstract] [Full Text] [Related]

  • 16. Effects of the systemic beta-adrenoceptor antagonist nebivolol on ocular hemodynamics in glaucoma patients.
    Zeitz O, Galambos P, Matthiesen N, Wagenfeld L, Schillinger W, Wiermann A, Richard G, Klemm M.
    Med Sci Monit; 2008 May 15; 14(5):CR268-275. PubMed ID: 18443551
    [Abstract] [Full Text] [Related]

  • 17. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar 15; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 18. Effect of nebivolol on QT dispersion in hypertensive patients with left ventricular hypertrophy.
    Galetta F, Franzoni F, Magagna A, Femia FR, Pentimone F, Santoro G, Carpi A.
    Biomed Pharmacother; 2005 Mar 15; 59(1-2):15-9. PubMed ID: 15740930
    [Abstract] [Full Text] [Related]

  • 19. [Use of nebivolol in patients with mild and moderate hypertension].
    Zhigunova LV, Lakhova EL, Iurenev AP.
    Ter Arkh; 2003 Mar 15; 75(3):59-61. PubMed ID: 12718224
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: results of a double-blind randomized multicentre trial.
    Grassi G, Trevano FQ, Facchini A, Toutouzas T, Chanu B, Mancia G.
    Blood Press Suppl; 2003 Dec 15; 2():35-40. PubMed ID: 14761075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.